Genotypic Versus Phenotypic Susceptibility Testing of Positive Blood Cultures

NAUnknownINTERVENTIONAL
Enrollment

774

Participants

Timeline

Start Date

May 23, 2019

Primary Completion Date

April 30, 2023

Study Completion Date

June 30, 2023

Conditions
Bloodstream Infection
Interventions
DIAGNOSTIC_TEST

Accelerate PhenoTest™ BC kit

The Accelerate PhenoTest™ BC kit with the Accelerate Pheno™ System is a fully-integrated in vitro diagnostic system. It is FDA-cleared to perform ID of bacteria and yeast in less than 90 minutes and AST in less than 7 hours, on average, directly from positive blood culture

DIAGNOSTIC_TEST

Standard of Care

Standard culture and AST of positive blood culture bottles plus the Verigene® BC-GP/GN

Trial Locations (1)

55415

Hennepin County Medical Center, Minneapolis

Sponsors
All Listed Sponsors
lead

Accelerate Diagnostics, Inc.

INDUSTRY

NCT03744728 - Genotypic Versus Phenotypic Susceptibility Testing of Positive Blood Cultures | Biotech Hunter | Biotech Hunter